1.
Borchmann P, Morschhauser F, Parry A, Schnell R, Harousseau J, Gisselbrecht C, Rudolph C, Wilhelm M, Gunther H, Pfreundschuh D, Camboni G, Engert A. Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin’s lymphomas. Haematologica [Internet]. 2003Aug.1 [cited 2026Nov.15];88(8):888-94. Available from: https://haematologica.org/article/view/2826